Physician profile
Robert Erlichman
NPI 1649633546
$3,189.51
in general payments reported to CMS, 2019-2025
8 companies · $24.90 in 2025
The $24.90 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $402 · 2022: $549 · 2023: $851 · 2024: $1,363 · 2025: $24.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,128 · Travel and Lodging: $865 · Education: $247.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.57 |
| Travel and Lodging | $864.50 |
| Education | $246.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Legacy Ortho LLC | $943.60 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $718.59 | 2021-2023 | Oxford |
| Arthrex, INC. | $615.30 | 2024 | |
| Smith+Nephew, INC. | $334.26 | 2022-2023 | Or3o Dual Mobility, Ri Hip Navigation, Trigen Intertan |
| Depuy Synthes Sales INC. | $290.70 | 2021-2025 | Va-Lcp, Fibergraft Aeridyan Matrix, Expert Nail |
| Stryker Corporation | $232.54 | 2021 | |
| Avanos Medical | $37.09 | 2024 | On-Q* Pump and Accessories |
| Medacta USA, INC. | $17.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Erlichman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.